The Urology Team at University Hospitals Coventry and Warwickshire NHS Trust (UHCW) has been involved in a number of the key trials of treatments for prostate cancer and has developed a variety of service and treatment innovations to streamline and enhance the patient experience.
Consultant Urological Surgeons Mr Kieran Jefferson and Mr Donald MacDonald will discuss the current ‘state of the art’ treatments available at UHCW and planned innovations for the near future at a Medicine for Members event on Thursday 21st March 2013, between 5.00pm-6.00pm. This event is being held in the Clinical Sciences Building at University Hospital, Coventry.
Mr Kieran Jefferson said: “Detection of prostate cancer has been improved in a number of ways, along with better selection for treatment. Surgical and radiotherapeutic techniques have changed dramatically to improve patient experience and minimize the long-term side effects of such treatments.
“For advanced disease, four new drugs have recently been licensed, each of which has been shown to extend survival and reduce symptoms. The Medicine for Members event is a great opportunity for the public to find out more about this and ask any questions they have about prostate cancer.”
To book a place for this session please contact Andrea Phillips, Membership Manager on 02476 964747 or email email@example.com.
FOR MORE INFORMATION ON THIS PRESS RELEASE PLEASE CONTACT SARAH CONLON, COMMUNICATIONS MANAGER ON 02476 967617.